KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Gross Profit (2016 - 2025)

Historic Gross Profit for Edwards Lifesciences (EW) over the last 17 years, with Q3 2025 value amounting to $1.2 billion.

  • Edwards Lifesciences' Gross Profit rose 1066.42% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 billion, marking a year-over-year increase of 840.28%. This contributed to the annual value of $4.3 billion for FY2024, which is 720.31% up from last year.
  • Latest data reveals that Edwards Lifesciences reported Gross Profit of $1.2 billion as of Q3 2025, which was up 1066.42% from $1.2 billion recorded in Q2 2025.
  • Edwards Lifesciences' 5-year Gross Profit high stood at $1.2 billion for Q3 2025, and its period low was $528.7 million during Q4 2022.
  • For the 5-year period, Edwards Lifesciences' Gross Profit averaged around $1.0 billion, with its median value being $1.0 billion (2022).
  • In the last 5 years, Edwards Lifesciences' Gross Profit plummeted by 4817.68% in 2022 and then soared by 9205.6% in 2023.
  • Quarter analysis of 5 years shows Edwards Lifesciences' Gross Profit stood at $1.0 billion in 2021, then tumbled by 48.18% to $528.7 million in 2022, then surged by 92.06% to $1.0 billion in 2023, then increased by 7.7% to $1.1 billion in 2024, then increased by 10.45% to $1.2 billion in 2025.
  • Its Gross Profit stands at $1.2 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.1 billion for Q1 2025.